The EHPL – European Health & Pharmaceutical Law identifies and analyses important legal and regulatory developments on the national, EU and international level. It is primarily concerned with pharmaceutical law, medicines law and issues related to the work of the European Medicines Agency (EMA).
Furthermore, it provides an overview of and critically examines judgments and directives that shape the interpretation and application of EU pharmaceutical law and policy, including those by the European Medicines Agency (EMA), European Courts, international courts and tribunals such as the WTO’s Dispute Settlement Body, and higher national courts.
EHPL’s Aims & Scope
In order to establish itself as a forum for dialogue between different stakeholders in pharmaceutical regulation and governance, EHPL invites contributions from academics, practitioners, regulators and civil society representatives.
Topics covered by EHPL include:
- Pharmaceutical law and policy in all jurisdictions (regional, national, international);
- Medicines law
- Commission decisions (EMA opinions) and regulatory guidelines;
- National, EU, and international jurisprudence;
- Medical devices;
- Borderline cases: pharmaceuticals/food/cosmetics/chemicals
- Patents /trademarks;
- Health technology assessment and pricing/reimbursement;
- Digital health/big data;
All contributions will be subject to double blind peer-review before acceptance for publication and are required to conform to the author guidelines.
EHPL’s Target Audience
The quarterly journal addresses everyone who is concerned with pharmaceutical law and policy issues such as academics (in the field of medicines law, regulatory science, and other relevant research fields), legal practitioners in national and international law firms, regulators such government officials working in EU and national public administration, judges and legal experts in domestic, European and international courts, consultancies, business people in the EU and beyond as well as stakeholder organisations representing professionals, patients, and civil society.
Each issue of EHPL will be a balanced mixture of original research articles, first-hand country or thematic policy reports, timely case annotations on important ECJ/GC rulings and other international/national court judgments, book reviews as well as other information material and updates, including opinions, case summaries or event reports.